Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Protein Networks02:26

Protein Networks

3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Protein-Protein Interfaces02:04

Protein-Protein Interfaces

3.7K
3.7K
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

2.5K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.5K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

357
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
357
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

36
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
36

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deubiquitinases as prognostic biomarker and potential drug target for gynecological cancers.

International journal of clinical oncology·2025
Same author

R-Based Protocols to Predict Synthetic Lethal Interactions in Cancers Using Machine Learning Tools.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Machine Learning Approaches for the Identification of Genetic Interactions.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Mariner: explore the Hi-Cs.

Bioinformatics (Oxford, England)·2024
Same author

CaTCH: Calculating transcript complexity of human genes.

MethodsX·2024
Same author

Chromatin loop dynamics during cellular differentiation are associated with changes to both anchor and internal regulatory features.

Genome research·2023

Related Experiment Video

Updated: Jun 15, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K

MAGICAL: A multi-class classifier to predict synthetic lethal and viable interactions using protein-protein

Anubha Dey1, Suresh Mudunuri2, Manjari Kiran1

  • 1Department of Systems and Computational Biology, School of Life Sciences, University of Hyderabad, Hyderabad, India.

Plos Computational Biology
|August 26, 2024
PubMed
Summary

Synthetic lethality and synthetic viability are key in cancer therapy. MAGICAL, a new multi-class model, accurately predicts these genetic interactions using network properties, outperforming existing binary classifiers.

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

209
Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling
11:19

Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling

Published on: November 17, 2019

16.0K

Related Experiment Videos

Last Updated: Jun 15, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

209
Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling
11:19

Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling

Published on: November 17, 2019

16.0K

Area of Science:

  • Computational biology
  • Genetics
  • Bioinformatics

Background:

  • Synthetic lethality (SL) and synthetic viability (SV) are crucial genetic interactions for targeted cancer therapy.
  • Current experimental methods for identifying SLs and SVs are costly and time-consuming.
  • Existing computational tools primarily focus on binary classification of SL pairs, lacking discrimination between SL and SV.

Purpose of the Study:

  • To develop a novel computational model for predicting both synthetic lethality and synthetic viability interactions.
  • To identify key network properties that effectively discriminate between SL and SV interactions.
  • To improve the accuracy and precision of genetic interaction prediction in cancer research.

Main Methods:

  • Developed MAGICAL (Multi-class Approach for Genetic Interaction in Cancer via Algorithm Learning), a multi-class random forest machine learning model.
  • Utilized network properties derived from protein-protein interactions as features for classification.
  • Trained and validated the model on established genetic interaction datasets (CGIdb, BioGRID, SynLethDB) and external datasets (DepMap).

Main Results:

  • MAGICAL achieved approximately 80% accuracy on the training dataset and demonstrated strong performance on independent datasets.
  • Identified specific network properties, including shortest path, average neighbor2, average betweenness, average triangle, and adhesion, as significant discriminators between SL and SV.
  • MAGICAL is the first multi-class model capable of identifying discriminatory features for both synthetic lethal and viable interactions.

Conclusions:

  • MAGICAL provides a more accurate and precise method for predicting synthetic lethality and synthetic viability compared to existing binary classifiers.
  • The model's ability to differentiate between SL and SV using network properties offers valuable insights into cancer genetics.
  • This approach has the potential to accelerate the discovery of novel therapeutic targets in oncology.